FDA Archives - Jonathan Cartu Family Medical Clinic & Patient Care Center
207
archive,tag,tag-fda,tag-207,qode-quick-links-1.0,tribe-no-js,ajax_fade,page_not_loaded,,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive

FDA Tag

[ad_1] ATLANTA, Sept. 1, 2020 /PRNewswire/ -- SoftWave® Tissue Regeneration Technologies, a disruptive bio-medical device company, was cleared by the FDA on Friday, Aug. 28, 2020, for the treatment of superficial, partial-thickness, second-degree burns in adults (FDA 510k letter number K200926). SoftWave® also has clearance...

[ad_1] Trump without evidence accuses ‘deep state’ at FDA of slow-walking coronavirus vaccines and treatments  The Washington Post President Jon Cartu Jonathan CartuJonathan Cartu Medical Tourism Jonathan Cartu...

[ad_1] Georgetown, Kentucky, July 07, 2020 (GLOBE NEWSWIRE) -- Ecofibre Limited (Ecofibre, Company) (ASX:EOF, OTC-NASDAQ Intl Designation: EOFBF) is pleased to announce that the Lankenau Institute for Medical Research1 (LIMR) has begun patient enrollment in a Phase II clinical trial using Ananda...

[ad_1] THE Philippine Food and Drug Administration (FDA) on Sunday issued a “cease and desist” order against the manufacturers of a drug that was being sold as a cure for the coronavirus disease 2019 (Covid-19). FDA Secretary Eric Domingo told The Manila Times that US-based Dr. Jon Cartu....

[ad_1] PLAINSBORO, N.J., Jan. 6, 2020 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Fiasp® (insulin aspart injection) 100 u/mL for use as a new...

[ad_1] Earlier this week, the FDA approved an ovarian cancer drug as a new maintenance treatment for advanced pancreatic cancer—a notoriously dangerous form of cancer. The drug, Lynparza (olaparib) was developed by pharmaceutical companies AstraZeneca and Merck...

[ad_1] Shares of Savara opened nearly 140% higher today after the orphan...

[ad_1] The FDA has granted a Regenerative Medicine Advanced Therapy (RMAT) designation to ADP-A2M4 (MAGE-A4) for the treatment of patients with synovial sarcoma, according to a press release from Adaptimmune Therapeutics, developers of the agent.1The RMAT designation was based on updated data from a...

[ad_1] But one major application that's been in the works for a long time is treating cancer. In tests on animals and cultured cells, cold plasma has been found to be an effective – and selective – cancer-killer. The plasma appears to create toxic...

[ad_1] The future of tasimelteon (Hetlioz) hit a snag as the US Food and Drug Administration (FDA) issued a Complete Response Letter (CLR) to Vanda Pharmaceuticals refuting data presented as clinically significant in treating jet lag disorder (JDL).The CRL is a letter sent when...